Vaccination of patients with advanced melanoma, pancreatic, colon and cervical cancer with HLA-A1, -A2 and -B35 restricted survivin peptides
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cancer vaccines; Montanide ISA-51
- Indications Cervical cancer; Colorectal cancer; Malignant melanoma; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 24 Mar 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 31 Aug 2006 The expected completion date for this trial is now .
- 28 Jul 2006 Biomarkers information updated